ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,626,626 | +17.9% | 133,602 | +33.5% | 0.04% | +8.3% |
| Q2 2023 | $3,076,472 | -9.9% | 100,113 | +5.7% | 0.04% | -21.7% |
| Q1 2023 | $3,412,972 | -1.0% | 94,739 | +8.6% | 0.05% | -4.2% |
| Q4 2022 | $3,447,799 | +2.6% | 87,275 | +4.4% | 0.05% | -2.0% |
| Q3 2022 | $3,361,000 | +5.7% | 83,618 | +10.6% | 0.05% | +53.1% |
| Q2 2022 | $3,179,000 | +8.0% | 75,577 | 0.0% | 0.03% | +33.3% |
| Q1 2022 | $2,944,000 | +91.4% | 75,577 | +95.9% | 0.02% | +100.0% |
| Q4 2021 | $1,538,000 | +10.3% | 38,574 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $1,394,000 | – | 38,574 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |